EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

NVTIA™ Tart Cherry-Celery Seed-Bromelain Core-Shell Composite for Uric Acid Management: Formulation Characterization and Translational Clinical Evidence

Jabar Yassine, Gregg L. Semenza, Valentina Rojas

Scientific Journal of Technology · 22.06.2026 · 8 (6) · 18-23

DOI: 10.54691/p6kf6j28 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Scientific Journal of Technology, online erschienen am 22.06.2026. Verfasst von Jabar Yassine und 2 weiteren Autor:innen. Die Arbeit nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hyperuricemia and gout remain clinically important metabolic-inflammatory conditions. Although plant-derived materials such as tart cherry products have been evaluated in human studies, single-ingredient or physically blended products often show inconsistent serum urate effects. We characterized NVTIA™ tart cherry-celery seed-bromelain composite raw material as a carrier-free core-shell system and interpreted its translational relevance against published human evidence on tart cherry and gout-related outcomes.

Methods

We prepared the composite by low-temperature polyphenol-phthalide pre-assembly, bromelain surface adsorption, microfluidization configuration locking, and lyophilization. Two formulation batches were compared with a conventional physical blend for particle size, redispersion behavior, apparent polyphenol solubility, and bromelain gastric-fluid tolerance. Published human studies of tart cherry juice, cherry intake, tart cherry concentrate, and tart cherry supplementary citrate mixture were used as clinical context for uric acid management.

Results

The NVTIA™ batches restored core-shell nanoparticles of 112-128 nm after reconstitution, with PDI values of 0.16-0.18. Reconstitution was completed within 22-25 s. Apparent total-polyphenol solubility reached 1.57-1.82 mg/mL, representing an 8.3-9.6-fold increase over the physical blend (0.19 mg/mL). Bromelain activity retention after simulated gastric-fluid exposure was 87.6%-89.2%. In contrast, the physical blend produced a coarse dispersion of 1427 nm, PDI 0.78, and slower redispersion. Published human evidence indicates that tart cherry juice can reduce serum urate in selected at-risk adults, cherry intake is associated with lower recurrent gout-attack risk, and tart cherry citrate mixtures may improve inflammatory or renal markers even when serum urate advantages are not superior to comparators.

Conclusion

We found that structuring tart cherry polyphenols, celery seed phthalides, and bromelain into a carrier-free core-shell powder substantially improves formulation-relevant performance compared with a conventional blend. The resulting physicochemical profile supports NVTIA™ as a clinically relevant candidate raw material for uric acid management research, particularly where improved dissolution, enzyme preservation, and multi-target metabolic-inflammatory support are desired.

Zitieren

APA

Yassine, J., Semenza, G. L., & Rojas, V. (2026). NVTIA™ Tart Cherry-Celery Seed-Bromelain Core-Shell Composite for Uric Acid Management: Formulation Characterization and Translational Clinical Evidence. Scientific Journal of Technology, 8(6), 18-23. https://doi.org/10.54691/p6kf6j28

Vancouver

Yassine J, Semenza GL, Rojas V. NVTIA™ Tart Cherry-Celery Seed-Bromelain Core-Shell Composite for Uric Acid Management: Formulation Characterization and Translational Clinical Evidence. Scientific Journal of Technology. 2026;8(6):18-23. doi:10.54691/p6kf6j28

BibTeX
@article{Yassine2026,
  author = {Yassine, Jabar and Semenza, Gregg L. and Rojas, Valentina},
  title = {NVTIA™ Tart Cherry-Celery Seed-Bromelain Core-Shell Composite for Uric Acid Management: Formulation Characterization and Translational Clinical Evidence},
  journal = {Scientific Journal of Technology},
  year = {2026},
  volume = {8},
  number = {6},
  pages = {18--23},
  doi = {10.54691/p6kf6j28}
}
Kostenlos starten →